Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Mumbai - 234-2 (30 ov), Sarfaraz Khan 6(3) Musheer Khan 26(25), need 3 runs Mumbai - 142-1 (20 ov), Rohit Sharma 98(60) Musheer Khan 1(2), need 95 runs Mumbai - 71-0 (10 ov), Rohit Sharma 54(29) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback